Non Small Cell Lung Cancer Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2026
SKU ID :FBUIN-15633850 | Published Date: 01-Jul-2019 | No. of pages: 160Description
TOC
The global non small cell lung cancer (NSCLC) therapeutics market size was valued at USD 16,011.7 Million in 2018 and is projected to reach USD 43,713.1 Million by the end of 2026, exhibiting a CAGR of 13.4% in the forecast period (2019-2026).
Tables & Figures
Companies
Genentech (F. Hoffmann-La Roche Ltd)
Eli Lilly and Company
Celgene Corporation
AstraZeneca
Pfizer Inc.
Sanofi
Novartis AG
Astellas
Bristol Myers Squibb
Boehringer Ingelheim Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. (Takeda)
Merck Sharp & Dohme Corp.
Other players
- PRICE
-
$4850$8850$6850Buy Now